Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

11.15 USD +0.23 (+2.11%)
Official Closing Price Updated: 7:59 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biocryst Pharma Inc

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
BioCryst Submits Marketing Authorization Application for UK Approval of ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema
From GlobeNewswire News Releases
Thinking about buying stock in Powerbridge Technologies, BioCryst Pharma, Oramed Pharma, Ampio Pharma, or Plus Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for PBTS, BCRX, ORMP, AMPE, and PSTV. 
From PR Newswire
BioCryst Receives Positive CHMP Opinion for ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema
From GlobeNewswire News Releases
BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results and Upcoming Key Milestones
From GlobeNewswire News Releases
BioCryst to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
BioCryst to Report Fourth Quarter and Full Year 2020 Financial Results on February 25
From GlobeNewswire News Releases
BioCryst to Present Data at 2021 American Academy of Allergy, Asthma & Immunology Annual Meeting
From GlobeNewswire News Releases
BioCryst Announces FDA Approval of Supplemental New Drug Application for RAPIVAB® Expanding Patient Population to Include Children Six Months and Older
From GlobeNewswire News Releases
Thinking about buying stock in Artelo Biosciences, Vaxart, Inovio Pharmaceuticals, Vyne Therapeutics, or BioCryst Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for ARTL, VXRT, INO, VYNE, and BCRX. 
From PR Newswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Thinking about buying stock in Avino Silver & Gold Mines, Comstock Mining, Phunware, BioCryst Pharmaceuticals, or Vertex Energy?
InvestorsObserver issues critical PriceWatch Alerts for ASM, LODE, PHUN, BCRX, and VTNR. 
From PR Newswire
Thinking about buying stock in iBio, Fluidigm Corp, Atossa Therapeutics, BioCryst Pharmaceuticals, or GameStop?
InvestorsObserver issues critical PriceWatch Alerts for IBIO, FLDM, ATOS, BCRX, and GME. 
From PR Newswire
BioCryst Announces Approval of ORLADEYO™ (berotralstat) in Japan for the Prophylactic Treatment of Hereditary Angioedema
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
BioCryst to Present at 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
Should you invest in Pfizer, Wells Fargo, American Airlines, BioCryst Pharmaceuticals, or Moderna?
InvestorsObserver issues critical PriceWatch Alerts for PFE, WFC, AAL, BCRX, and MRNA. 
From PR Newswire
BioCryst Provides Update on Galidesivir Program
From GlobeNewswire News Releases
BioCryst Announces Positive Phase 1 Results with BCX9250, an Oral ALK-2 Inhibitor for Treatment of Fibrodysplasia Ossificans Progressiva
From GlobeNewswire News Releases
BioCryst Announces U.S. Availability of ORLADEYO™ (berotralstat) for the Treatment of Hereditary Angioedema
From GlobeNewswire News Releases
Thinking about buying stock in Inseego Corp, Ampio Pharmaceuticals, Marathon Patent Group, Regulus Therapeutics, or BioCryst Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for INSG, AMPE, MARA, RGLS, and BCRX. 
From PR Newswire
BioCryst to Present at JMP Securities Hematology Summit
From GlobeNewswire News Releases
Thinking about buying stock in Curis, Blink Charging, BioCryst Pharmaceuticals, Electrameccanica Vehicles, or Uranium Energy?
InvestorsObserver issues critical PriceWatch Alerts for CRIS, BLNK, BCRX, SOLO, and UEC. 
From PR Newswire
Thinking about trading options or stock in Rambus, Intellia Therapeutics, BioCryst Pharmaceuticals, Arcturus Therapeutics, or FuelCell Energy?
InvestorsObserver issues critical PriceWatch Alerts for RMBS, NTLA, BCRX, ARCT, and FCEL. 
From PR Newswire
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
From GlobeNewswire News Releases
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
From GlobeNewswire News Releases
BioCryst’s Oral Factor D Inhibitor (BCX9930) Shows High Potency and Specificity for Alternative Pathway of Complement
From GlobeNewswire News Releases
Thinking about buying stock in Sutro Biopharma, BioCryst Pharmaceuticals, Inovio Pharmaceuticals, Cocrystal Pharma, or Clean Energy Fuels?
InvestorsObserver issues critical PriceWatch Alerts for STRO, BCRX, INO, COCP, and CLNE. 
From PR Newswire
BioCryst Announces FDA Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Allergy Publishes Results from BioCryst’s APeX-J Trial of Oral, Once-Daily Berotralstat for the Prevention of HAE Attacks
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account